Showing results (1021-1030 of 1,051) with videos related to

Sort By:
Pageof 106
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencingK C Allen Chan, Peiyong Jiang, Carol W M Chan, et al.
The New England Journal of Medicine|August 10, 2017
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal CancerK C Allen Chan, John K S Woo, Ann King, et al.
Bone Marrow Transplantation|November 12, 2013
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab eraC P Fox, D Burns, A N Parker, et al.
Nature Medicine|July 19, 2024
Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklistSiew S Lim, Zhila Semnani-Azad, Mario L Morieri, et al.
Cancer Discovery|March 1, 2020
Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and TransplantationPeiyong Jiang, Kun Sun, Wenlei Peng, et al.
Genome Research|November 27, 2024
Analysis of a cell-free DNA-based cancer screening cohort links fragmentomic profiles, nuclease levels, and plasma DNA concentrationsYasine Malki, Guannan Kang, W K Jacky Lam, et al.
The American Journal of Pathology|February 27, 2007
Hypermethylation of RASSF1A in human and rhesus placentasRossa W K Chiu, Stephen S C Chim, Ivy H N Wong, et al.
Cell Genomics|February 7, 2026
Holistic determination of ends of cfDNA moleculesPeiyong Jiang, Mary-Jane L Ma, Rong Qiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2022
Epigenetic analysis of cell-free DNA by fragmentomic profilingQing Zhou, Guannan Kang, Peiyong Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled TrialAnthony T C Chan, Edwin P Hui, Roger K C Ngan, et al.
Pageof 106